Ezetimibe BE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-09-30 17:26 (2088 d 01:55 ago) – Posting: # 20657
Views: 6,079

Hi ElMaestro,

❝ "The applicant should document that the enzymatic de-conjugation can be considered quantitative under assay conditions"


:-D:vomit:


That would be a valid request. Has to be determined in method development & validation. No big deal, since β-glucuronidase is used for decades.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
25 visitors (0 registered, 25 guests [including 11 identified bots]).
Forum time: 19:22 CEST (Europe/Vienna)

Truth and clarity are complementary.    Niels Bohr

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5